Ambrx Biopharma shares owned by Citadel Advisors
Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Ambrx Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Ambrx Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Ambrx Biopharma by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $31M | 2.1M | 14.24 |
Top funds holding Ambrx Biopharma
View all funds holding Ambrx Biopharma